|Truffle Capital||Life Sciences Partner||France|
WHAT IS THE RIGHT BALANCE BETWEEN EQUITY, ROYALTIES AND COLLABORATIVE RESEARCH INCOME FOR ACADEMIC INSTITUTIONS THAT ARE IN THE PROCESS OF SPINNING OUT COMPANIES?
Alain is a Life Science Partner at Truffle Capital where he contributes to the fundraising efforts, leads deal sourcing from academia and provides strategic support to portfolio companies.
He joined the firm in 2007 as a Venture Partner before being promoted to his current role in 2016. Among other projects, Alain co-founded Splicos SAS (now Abivax) with Truffle Capital (2008), served as Chief Financial Officer of Deinove (2010) and Abivax (2013), and as Chairman of Carbios (2011). During his tenure, he successfully listed Deinove, Abivax and Carbios on the Euronext stock exchange.
Alain was previously a senior executive at Sanofi where he spent 30 years developing the business globally. During his time with the firm, he served as CEO in Central America and in Japan and eventually CFO of Aventis Pharma SA then Sanofi Aventis France.
Alain holds an MBA in Finance and Accounting from HEC Paris (Ecole des Hautes Etudes Commerciales-Paris).